Diagnostic approach to microangiopathic hemolytic disorders

Area of Science:

• Hematology
• Nephrology
• Pathology

Background:

• Thrombotic micro-angiopathies (TMAs) are a spectrum of disorders characterized by microvascular thrombosis and organ dysfunction.
• Hallmarks include microangiopathic hemolytic anemia due to erythrocyte fragmentation.

Purpose of the Study:

• To highlight the importance of distinguishing between different TMA subtypes.
• To emphasize how accurate diagnosis guides distinct and potentially life-saving therapeutic strategies.

Main Methods:

• Review of distinct pathophysiologies leading to microangiopathic hemolysis.
• Discussion of laboratory tests for TMA diagnosis: ADAMTS13 activity, ADAMTS13 inhibitor levels, shiga toxin assays, and complement factor analysis.

Main Results:

• TMAs encompass diverse etiologies including decreased von Willebrand factor degradation (e.g., thrombotic thrombocytopenic purpura), endothelial damage from Escherichia coli shiga toxin (shiga toxin-related hemolytic-uremic syndrome), and complement dysregulation (complement-mediated TMA/atypical hemolytic-uremic syndrome).
• Laboratory testing aids in differentiating these conditions.

Conclusions:

• Accurate diagnosis of TMAs is critical due to their life-threatening nature and distinct treatment requirements.
• Appropriate therapeutic selection based on laboratory findings can significantly improve patient prognosis.